Atazanavir Sulfate
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
65862-710 -
Package NDC
65862-710-03 -
Package NDC
65862-710-05 -
Package NDC
65862-710-60 -
Application number
ANDA204806 -
SPL ID
8f8c56e0-40ee-4643-88f7-d3571ff5a409 -
SPL set ID
7fbea274-d6b5-4faa-bbf0-05fefab42114 -
UNII
4MT4VIE29P -
RxCUI
402245 -
RxCUI
402246 -
RxCUI
402247 -
RxCUI
664741
What the source publishes
- Labeler
- Aurobindo Pharma Limited
- Active ingredients
- Atazanavir
- Form
- CAPSULE
- Routes
- ORAL
- Administrative status
- present-in-source-snapshot
- Marketing status
- ANDA
- Product type
- HUMAN PRESCRIPTION DRUG
- Prescription
- Prescription or restricted
Names this record is found by
Complete source data
{
"name": "Atazanavir Sulfate",
"splId": "8f8c56e0-40ee-4643-88f7-d3571ff5a409",
"labels": [
{
"setId": "7fbea274-d6b5-4faa-bbf0-05fefab42114",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=7fbea274-d6b5-4faa-bbf0-05fefab42114",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=7fbea274-d6b5-4faa-bbf0-05fefab42114"
}
],
"routes": [
"ORAL"
],
"labeler": "Aurobindo Pharma Limited",
"finished": true,
"packaging": [
{
"sample": false,
"description": "3 BLISTER PACK in 1 CARTON (65862-710-03) / 10 CAPSULE in 1 BLISTER PACK (65862-710-10)",
"package_ndc": "65862-710-03",
"identifierStatus": "well-formed",
"marketing_start_date": "20180625"
},
{
"sample": false,
"description": "500 CAPSULE in 1 BOTTLE (65862-710-05)",
"package_ndc": "65862-710-05",
"identifierStatus": "well-formed",
"marketing_start_date": "20180625"
},
{
"sample": false,
"description": "60 CAPSULE in 1 BOTTLE (65862-710-60)",
"package_ndc": "65862-710-60",
"identifierStatus": "well-formed",
"marketing_start_date": "20180625"
}
],
"productId": "65862-710_8f8c56e0-40ee-4643-88f7-d3571ff5a409",
"useDomain": "unknown",
"dosageForm": "CAPSULE",
"productNdc": "65862-710",
"deaSchedule": null,
"genericName": "Atazanavir",
"productType": "HUMAN PRESCRIPTION DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [
{
"name": "ATAZANAVIR SULFATE",
"strength": "100 mg/1"
}
],
"applicationNumber": "ANDA204806",
"marketingCategory": "ANDA",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20180625",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "prescription-or-restricted",
"harmonizedIdentifiers": {
"unii": [
"4MT4VIE29P"
],
"rxcui": [
"402245",
"402246",
"402247",
"664741"
],
"spl_set_id": [
"7fbea274-d6b5-4faa-bbf0-05fefab42114"
],
"manufacturer_name": [
"Aurobindo Pharma Limited"
],
"is_original_packager": [
true
]
},
"listingExpirationDate": "20271231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:65862-710_8f8c56e0-40ee-4643-88f7-d3571ff5a409"